Either we get ahead of this crisis or watch a generation of Americans be swept into the devastating grip of disease.
To tackle HIV/AIDS in South Africa, China, through the China Global Development and South-South Cooperation Fund, has announced a two-year funding commitment of 3.49 million U.S. dollars.
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
Zacks Investment Research on MSN
MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC
Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
To mark World AIDS Day, the Institute for Contemporary Arts will screen our film tackling the collapse of USAID funding ...
New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...
A fish and chip shop owner has credited a charity which has supported him for more than 20 years after receiving his HIV diagnosis with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results